Newswise — New York, NY (July 25, 2018) – The American Thoracic Society led 10 medical professional organizations in filing an amicus brief last week regarding the FDA’s failure to apply pre-market review to new tobacco products. The brief was submitted in support of the American Academy of Pediatrics and its co-plaintiffs and outlines the compelling data indicating that the FDA’s failure to act harms children.
At the crux of the suit brought by the American Academy of Pediatrics against the FDA is the agency’s failure to apply its pre-market review authority to tobacco products that were introduced to the U.S. market after February 2007. It is the view of the ATS that the Family Smoking Prevention and Tobacco Control Act gave the FDA the authority and obligation to conduct pre-market review of all tobacco products that were introduced to the U.S. market after February 2007. E-cigarettes and a new generation of candy-flavored tobacco products that are heavily marketed to children have not undergone FDA pre-market review.
In 2016, the FDA issued a schedule for conducting pre-market review of cigars and e-cigarettes. However, the Trump Administration announced substantial delays (as long as four years for some products) in the schedule originally announced by the FDA.
The amicus brief filed by ATS and other organizations aims to share with the court the available evidence illustrating that the FDA’s inaction is currently causing harm and will continue to cause harm. Without pre-market review requirements, big tobacco will continue to have the luxury of time to amplify their marketing to children, who are the key target for candy-flavored tobacco products. With exposure to these products come the potential for addiction.
The full list of amici include: the American Thoracic Society; the American Medical Association; the American Academy of Allergy, Asthma and Immunology; American Association of Respiratory Care, American College of Chest Physicians; the American College of Occupational and Environmental Medicine; the American College of Preventive Medicine; the American Public Health Association; the National Association for the Medical Direction of Respiratory Care; the National Center for Health Research; and the National Medical Association.
ATS Members Available for Comment:
About the American Thoracic Society
Founded in 1905, the American Thoracic Society is the world's leading medical association dedicated to advancing pulmonary, critical care and sleep medicine. The Society’s 15,000 members prevent and fight respiratory disease around the globe through research, education, patient care and advocacy. The ATS publishes three journals, the American Journal of Respiratory and Critical Care Medicine, the American Journal of Respiratory Cell and Molecular Biology and the Annals of the American Thoracic Society.
The ATS will hold its 2019 International Conference, May 17-22, in Dallas, Texas, where world-renowned experts will share the latest scientific research and clinical advances in pulmonary, critical care and sleep medicine.
MEDIA CONTACTRegister for reporter access to contact details
2019 International Conference, May 17-22, 2019